Nordic Nanovector ASA (NANO) - Financial and Strategic SWOT Analysis Review
Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of hematological cancers. The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed for the treatment of non-Hodgkin Lymphoma, a life-threatening blood cancer. Its Betalutin consists of tumor-specific antibody HH1, which targets CD37 antigen on the surface of NHL cells. Nordic Nanovector develops products for the treatment of multiple cancer indications by utilizing innovative therapy programs and patented technologies. The company evaluates chimeric anti-CD37 antibodies with different payloads for the treatment of both types of leukemia. It operates in Norway, Switzerland and the UK. Nordic Nanovector is headquartered in Oslo, Norway.
Nordic Nanovector ASA Key Recent Developments
May 26,2020: Nordic Nanovector : Results for the first quarter 2020
May 04,2020: Nordic Nanovector announces changes to its executive management team
Mar 23,2020: Nordic Nanovector appoints Dr Dominic Smethurst as interim chief medical officer
Mar 19,2020: Nordic Nanovector announces proposed board change
Mar 19,2020: Nordic Nanovector announces proposed board change
This comprehensive SWOT profile of Nordic Nanovector ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nordic Nanovector ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Section 1 - About the Company
Nordic Nanovector ASA - Key Information
Nordic Nanovector ASA - Overview
Nordic Nanovector ASA - Key Employees
Nordic Nanovector ASA - Key Employee Biographies
Nordic Nanovector ASA - Key Operational Heads
Nordic Nanovector ASA - Major Products and Services
Nordic Nanovector ASA - History
Nordic Nanovector ASA - Company Statement
Nordic Nanovector ASA - Locations And Subsidiaries
Nordic Nanovector ASA
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Nordic Nanovector ASA - Business Description
Nordic Nanovector ASA - Corporate Strategy
Nordic Nanovector ASA - SWOT Analysis
SWOT Analysis - Overview
Nordic Nanovector ASA - Strengths
Nordic Nanovector ASA - Weaknesses
Nordic Nanovector ASA - Opportunities
Nordic Nanovector ASA - Threats
Nordic Nanovector ASA - Key Competitors
Section 3 - Company Financial Performance Charts
Nordic Nanovector ASA - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
List Of Tables
Nordic Nanovector ASA, Key Information
Nordic Nanovector ASA, Key Ratios
Nordic Nanovector ASA, Share Data
Nordic Nanovector ASA, Major Products and Services
Nordic Nanovector ASA, History
Nordic Nanovector ASA, Key Employees
Nordic Nanovector ASA, Key Employee Biographies
Nordic Nanovector ASA, Key Operational Heads
Nordic Nanovector ASA, Other Locations
Nordic Nanovector ASA, Subsidiaries
Nordic Nanovector ASA, Key Competitors
Nordic Nanovector ASA, SWOT Analysis
Nordic Nanovector ASA, Ratios based on current share price
Nordic Nanovector ASA, Annual Ratios
Nordic Nanovector ASA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List Of Figures
Nordic Nanovector ASA, Performance Chart
Nordic Nanovector ASA, Ratio Charts
Bavarian Nordic A/S (BAVA) - Financial and Strategic SWOT Analysis Review
Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using its poxvirus-based technology
USD 300 View ReportFill The Form For Sample Request